Twenty-eight percent of trials used historical, external, or other control; nearly half used surrogate measure as a primary end point

Existing sleep problems related mainly to disease-related measures, such as pain and reduced function, more so than disease duration

Larger volume associated with severity of cognitive impairment across Alzheimer disease spectrum

Larger volume associated with severity of cognitive impairment across Alzheimer disease spectrum

Low-burden, point-of-care program may increase access to and impact of treatment to assist tobacco cessation